Targeting DNA repair pathways: a novel approach to reduce cancer therapeutic resistance

Yongjian Zhu1, Jue Hu, Yiduo Hu

  • 1Department of Neurosurgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, China. yongjian_zhu@zju.edu.cn

Insights

Targeting cancer cell DNA repair pathways can overcome chemo-resistance and radio-resistance. Inhibiting these repair mechanisms with novel pharmacological agents offers a promising strategy to enhance anticancer treatment efficacy and reverse therapeutic resistance.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Therapeutic resistance to chemotherapy and radiotherapy is a significant challenge in cancer treatment.
  • Cancer cells employ DNA repair pathways to mend damage induced by anticancer agents and radiation, contributing to resistance.
  • Understanding these DNA repair mechanisms is crucial for developing more effective cancer therapies.

Purpose of the Study:

  • To review major DNA repair pathways involved in cancer therapeutic resistance.
  • To discuss recent advancements in developing inhibitors for these DNA repair pathways.
  • To highlight the potential of DNA repair inhibitors in enhancing anticancer treatment efficacy.

Main Methods:

  • Literature review of DNA repair pathways in cancer.
  • Analysis of recent preclinical and clinical investigations on DNA repair inhibitors.
  • Discussion of pharmacological strategies to target DNA repair mechanisms.

Main Results:

  • Several major DNA repair pathways contribute to cancer cell resistance.
  • Novel pharmacological inhibitors targeting these pathways are under active development.
  • These inhibitors show promise in preclinical and clinical settings.

Conclusions:

  • Inhibiting DNA repair pathways is a viable strategy to overcome chemo-resistance and radio-resistance.
  • Pharmacological agents targeting DNA repair offer a promising avenue for improving cancer treatment outcomes.
  • Further research and clinical investigation of DNA repair inhibitors are warranted.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Overview of DNA Repair02:25

Overview of DNA Repair

In order to be passed through generations, genomic DNA must be undamaged and error-free. However, every day, DNA in a cell undergoes several thousand to a million damaging events by natural causes and external factors. Ionizing radiation such as UV rays, free radicals produced during cellular respiration, and hydrolytic damage from metabolic reactions can alter the structure of DNA. Damages caused include single-base alteration, base dimerization, chain breaks, and cross-linkage.
Chemically...
Overview of DNA Repair02:25

Overview of DNA Repair

In order to be passed through generations, genomic DNA must be undamaged and error-free. However, every day, DNA in a cell undergoes several thousand to a million damaging events by natural causes and external factors. Ionizing radiation such as UV rays, free radicals produced during cellular respiration, and hydrolytic damage from metabolic reactions can alter the structure of DNA. Damages caused include single-base alteration, base dimerization, chain breaks, and cross-linkage.
Chemically...